Publications
Detailed Information
A phase II study of brentuximab vedotin in patients with relapsed or refractory Epstein-Barr virus-positive and CD30-positive lymphomas
Cited 7 time in
Web of Science
Cited 7 time in Scopus
- Authors
- Issue Date
- 2021-08
- Publisher
- Ferrata Storti Foundation
- Citation
- Haematologica, Vol.106 No.8, pp.2277-2280
- ISSN
- 0390-6078
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.